Association between parental histories of hypertension, diabetes and dyslipidemia and the clustering of these disorders in offspring

Preventive Medicine
Keiko WadaHideaki Toyoshima

Abstract

Familial aggregation of hypertension, diabetes and dyslipidemia has been well reported. However, only a few studies have assessed to what extent parental histories were involved in the clustering of these diseases. In 2002, associations between parental histories of hypertension, diabetes and dyslipidemia and the clustering of high blood pressure, hyperglycemia and dyslipidemia in individuals were assessed on the basis of 5010 Japanese men and women aged 33-66 years. Risk factor clusters were defined as those having at least two of the three clinical disorders. Compared with persons with no parental history of the three diseases, those who had 1, 2 and 3 or more parental histories had risk factor clusters, 1.25 (95% CI: 1.07, 1.47), 1.46 (95% CI: 1.16, 1.84) and 1.41 (95% CI: 0.95, 2.11) times higher, respectively, after adjusting for confounding factors. ORs by 1, 2 and 3 of maternal history were 1.33 (95% CI: 1.12, 1.58), 1.65 (95% CI: 1.16, 2.35) and 1.69 (95% CI: 0.64, 4.42), respectively (trend P < 0.001). However, the number of paternal history was not associated with risk factor clusters. We conclude that familial history, particularly maternal history, is an important aid to prevention strategy and public health practic...Continue Reading

References

May 18, 1991·BMJ : British Medical Journal·J C Alcolado, R Alcolado
Dec 11, 1993·BMJ : British Medical Journal·F KeeF Cambien
Feb 1, 1993·Journal of Clinical Epidemiology·M HeliövaaraO Impivaara
Jan 1, 1997·Annual Review of Genetics·M S Bartolomei, S M Tilghman
Jul 22, 1999·Genetic Epidemiology·J T BensenM Higgins
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Sep 5, 2001·Clinical Genetics·A L DeStefanoF Schwartz
Dec 14, 2001·Nature·P Maechler, C B Wollheim
Dec 4, 2002·JAMA : the Journal of the American Medical Association·Hanna-Maaria LakkaJukka T Salonen
Jan 24, 2003·International Journal of Epidemiology·D J P BarkerC Osmond
May 17, 2003·Science·Kitt Falk PetersenGerald I Shulman
Mar 17, 2004·Annals of Internal Medicine·Joanne M MurabitoPeter W F Wilson
Sep 17, 2004·Journal of Human Hypertension·T KondoUNKNOWN JACC Study Group
Oct 23, 2004·Science·Frederick H WilsonRichard P Lifton

❮ Previous
Next ❯

Citations

Jun 19, 2013·Indian Journal of Endocrinology and Metabolism·Syed M S AndrabiUmara Nisar
Apr 29, 2009·BMC Endocrine Disorders·Athanasia PapazafiropoulouStavros Pappas
Jul 14, 2011·Journal of Clinical Research in Pediatric Endocrinology·Özlem SangunNihal Dündar
Sep 7, 2011·European Journal of Public Health·Elisabeth KvaavikG David Batty
Oct 16, 2007·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Roya KelishadiUNKNOWN CASPIAN Study Group
Oct 26, 2011·Community Dentistry and Oral Epidemiology·Dara M ShearerRichie Poulton
Jul 20, 2010·Community Dentistry and Oral Epidemiology·Dara M Shearer, W Murray Thomson
Sep 25, 2014·Diabetic Medicine : a Journal of the British Diabetic Association·P KatulandaD R Matthews
Jun 8, 2011·Laboratory Investigation; a Journal of Technical Methods and Pathology·David M KrzywanskiScott W Ballinger
Oct 27, 2018·Current Hypertension Reports·Ștefania MateiBogdan Dorobanțu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.